标题
The role of bevacizumab in the treatment of glioblastoma
作者
关键词
Avastin, Bevacizumab, VEGF, Glioblastoma, Chemotherapy, Survival
出版物
JOURNAL OF NEURO-ONCOLOGY
Volume 133, Issue 3, Pages 455-467
出版商
Springer Nature
发表日期
2017-05-19
DOI
10.1007/s11060-017-2477-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
- (2017) Sith Sathornsumetee et al. NEURO-ONCOLOGY
- Pharmacotherapies for the treatment of glioblastoma – current evidence and perspectives
- (2016) Katharina Seystahl et al. EXPERT OPINION ON PHARMACOTHERAPY
- Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
- (2016) Ulrich Herrlinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Adverse events risk associated with anti-VEGFR agents in the treatment of advanced nonsmall-cell lung cancer
- (2016) Biao Gu et al. MEDICINE
- Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
- (2016) Han Yang et al. OncoTargets and Therapy
- MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
- (2015) M. Weller et al. CLINICAL CANCER RESEARCH
- The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
- (2015) Linda Dirven et al. EUROPEAN JOURNAL OF CANCER
- Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
- (2015) Martin J.B. Taphoorn et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
- (2015) Yazmin Odia et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
- (2015) E. Q. Lee et al. NEURO-ONCOLOGY
- Bevacizumab in Combination With Radiotherapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2015) M. E. van Linde et al. ONCOLOGIST
- Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study
- (2014) Kenneth F. Hofland et al. ACTA ONCOLOGICA
- Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?
- (2014) Alba A Brandes et al. Future Oncology
- Benefit of tumor resection for recurrent glioblastoma
- (2014) Johanna Quick et al. JOURNAL OF NEURO-ONCOLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis of Median Survival Time in Meta-analysis
- (2013) Jiajie Zang et al. EPIDEMIOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
- (2013) Riccardo Soffietti et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy
- (2012) Søren Møller et al. ACTA ONCOLOGICA
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Bevacizumab and daily temozolomide for recurrent glioblastoma
- (2011) Annick Desjardins et al. CANCER
- The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
- (2011) J. J. Vredenburgh et al. CLINICAL CANCER RESEARCH
- Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma
- (2011) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
- (2011) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- Addition of Bevacizumab to Standard Radiation Therapy and Daily Temozolomide Is Associated With Minimal Toxicity in Newly Diagnosed Glioblastoma Multiforme
- (2010) James J. Vredenburgh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2010) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab and chemotherapy for recurrent glioblastoma: A single-institution experience
- (2009) P. L. Nghiemphu et al. NEUROLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme
- (2008) Camilo E. Fadul et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
- (2008) Vinay K. Puduvalli et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started